HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.500 |
None |
1.000 |
36 |
4
|
2003 |
2019 |
Spondylarthropathies
|
group |
Musculoskeletal Diseases
|
Disease or Syndrome
|
92
|
7
|
0.100 |
None |
1.000 |
24 |
|
1994 |
2020 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.100 |
None |
0.938 |
16 |
1
|
1991 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.929 |
14 |
1
|
1989 |
2019 |
Inflammatory Bowel Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1577
|
605
|
0.200 |
None |
1.000 |
12 |
1
|
2000 |
2020 |
Inflammatory disorder
|
group |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
391
|
8
|
0.100 |
None |
0.909 |
11 |
|
1995 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.070 |
None |
1.000 |
7 |
|
2001 |
2017 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.160 |
None |
1.000 |
7 |
1
|
1982 |
2019 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
6 |
|
1980 |
2018 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
6 |
|
1980 |
2018 |
Acquired Immunodeficiency Syndrome
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
243
|
42
|
0.140 |
None |
1.000 |
5 |
2
|
1999 |
2009 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.050 |
None |
1.000 |
5 |
|
2001 |
2017 |
Collagen Diseases
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
63
|
10
|
0.040 |
None |
1.000 |
4 |
|
2016 |
2019 |
Cytomegalovirus Infections
|
group |
Infections
|
Disease or Syndrome
|
462
|
26
|
0.040 |
None |
1.000 |
4 |
|
2000 |
2018 |
Drug Eruptions
|
group |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
41
|
|
0.320 |
None |
1.000 |
4 |
|
2009 |
2018 |
Drug Allergy
|
group |
Immune System Diseases; Chemically-Induced Disorders
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
4 |
|
2002 |
2007 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.040 |
None |
1.000 |
4 |
|
2005 |
2019 |
Herpes zoster disease
|
group |
Infections
|
Disease or Syndrome
|
51
|
10
|
0.130 |
None |
1.000 |
3 |
1
|
1989 |
2019 |
Hypersensitivity
|
group |
Immune System Diseases
|
Pathologic Function
|
90
|
2
|
0.410 |
None |
1.000 |
3 |
1
|
2007 |
2017 |
Virus Diseases
|
group |
Infections
|
Disease or Syndrome
|
1471
|
42
|
0.030 |
None |
1.000 |
3 |
|
1986 |
2017 |
Chronic inflammatory disorder
|
group |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
74
|
|
0.030 |
None |
1.000 |
3 |
|
2019 |
2019 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.030 |
None |
1.000 |
3 |
1
|
2001 |
2016 |
Mental disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
789
|
149
|
0.020 |
None |
1.000 |
2 |
|
1993 |
2019 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.020 |
None |
1.000 |
2 |
|
1989 |
1989 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.020 |
None |
0.500 |
2 |
|
1996 |
2010 |